找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Recombinant Protein Drugs; Peter Buckel Book 2001 Birkh?user Verlag 2001 clinic.clinical trial.development.drug.drug discovery.drugs.futur

[復制鏈接]
查看: 36750|回復: 42
樓主
發(fā)表于 2025-3-21 17:04:44 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Recombinant Protein Drugs
編輯Peter Buckel
視頻videohttp://file.papertrans.cn/825/824097/824097.mp4
叢書名稱Milestones in Drug Therapy
圖書封面Titlebook: Recombinant Protein Drugs;  Peter Buckel Book 2001 Birkh?user Verlag 2001 clinic.clinical trial.development.drug.drug discovery.drugs.futur
描述Recombinant protein drugs are intimately associated with the impressive success story of the Biotech Industry during the past thirty years, some of them belonging to the most successful pharmaceutical products. More than thirty different proteins are available for a variety of clinical applications, over 300 proteins are presently being evaluated in clinical trials. In this new volume of the MDT series, historical, technical and clinical aspects of recombinant protein drug discovery and development are presented, covering past, present and future highlights. Leading scientists and co-founders of early Biotech companies describe technical breakthroughs and the fascinating story of pioneering discoveries, as well as the long way of translating them into products and business. Therefore, this book represents an exciting documentation of the beginning of a new era in the pharmaceutical industry. In addition, scientists from basic research, clinic and industry actively involved in new developments discuss...
出版日期Book 2001
關鍵詞clinic; clinical trial; development; drug; drug discovery; drugs; future; gene therapy; hepatitis; interferon
版次1
doihttps://doi.org/10.1007/978-3-0348-8346-7
isbn_softcover978-3-0348-9527-9
isbn_ebook978-3-0348-8346-7Series ISSN 2296-6056 Series E-ISSN 2296-6064
issn_series 2296-6056
copyrightBirkh?user Verlag 2001
The information of publication is updating

書目名稱Recombinant Protein Drugs影響因子(影響力)




書目名稱Recombinant Protein Drugs影響因子(影響力)學科排名




書目名稱Recombinant Protein Drugs網絡公開度




書目名稱Recombinant Protein Drugs網絡公開度學科排名




書目名稱Recombinant Protein Drugs被引頻次




書目名稱Recombinant Protein Drugs被引頻次學科排名




書目名稱Recombinant Protein Drugs年度引用




書目名稱Recombinant Protein Drugs年度引用學科排名




書目名稱Recombinant Protein Drugs讀者反饋




書目名稱Recombinant Protein Drugs讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:57:08 | 只看該作者
lead to other problems. For example, if the compressor “l(fā)ocks-up”, the belt which connects the compressor to the engine may break and get caught in some of the moving parts of the engine. In essence, the importance of the compressor to the air conditioning system is like that of the heart to the hum
板凳
發(fā)表于 2025-3-22 03:46:31 | 只看該作者
地板
發(fā)表于 2025-3-22 06:22:09 | 只看該作者
Peter Hans Hofschneider,Kenneth Murrayons by the human operators. During the teaching mode, operation details are stored for future repetitive replays. Since human intervention is required, system autonomy is reduced. The other approach involves the use of textual programming. A system is given the assembly plan in terms of operation de
5#
發(fā)表于 2025-3-22 12:14:30 | 只看該作者
6#
發(fā)表于 2025-3-22 13:47:44 | 只看該作者
7#
發(fā)表于 2025-3-22 17:45:43 | 只看該作者
8#
發(fā)表于 2025-3-22 23:40:30 | 只看該作者
Theodore Friedmannticipate and eliminate high risk or high cost production problems. The key to successful implementation of a producibility engineering program is a management committment to the allocation of sufficient resources to insure that design concepts have been subjected to thorough analyses before the desi
9#
發(fā)表于 2025-3-23 04:12:30 | 只看該作者
10#
發(fā)表于 2025-3-23 06:15:48 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-8 14:12
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
宁陕县| 广水市| 尼玛县| 涿鹿县| 四会市| 昌图县| 莆田市| 景泰县| 西乡县| 五大连池市| 西林县| 武强县| 宝应县| 凤阳县| 镇赉县| 尤溪县| 安新县| 榆树市| 南澳县| 黄梅县| 洞头县| 新营市| 温宿县| 宁明县| 淮安市| 和硕县| 汶上县| 北票市| 达孜县| 大田县| 会理县| 沾化县| 平定县| 利川市| 双桥区| 孝义市| 上犹县| 贡觉县| 石阡县| 喀什市| 天水市|